Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 19, 2026 | CMS / Medicare | Respiratory Care | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors | Metadata changed |
| May 19, 2026 | CMS / Medicare | In Vitro Chemosensitivity & Chemoresistance Assays | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: White Cell Colony Stimulating Factors | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: High Sensitivity C-Reactive Protein (hsCRP) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology | Metadata changed |
| May 19, 2026 | CMS / Medicare | Trigger Point Injections (TPI) | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Vitamin D Assay Testing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Implantable Infusion Pump | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Transcranial Magnetic Stimulation (TMS) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Testopel Coverage | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Lab: Cystatin C Measurement | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lumbar MRI | Metadata changed |
| May 19, 2026 | CMS / Medicare | BDX-XL2 | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Total Hip Arthroplasty | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Lab: Bladder/Urothelial Tumor Markers | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Measurement of Salivary Hormones | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Total Hip Arthroplasty | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: DecisionDx-UM (Uveal Melanoma) | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers â Coding and Billing | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy DL36408 | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Treatment of Males with Low Testosterone | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Stretta Procedure | Metadata changed |
| May 19, 2026 | CMS / Medicare | Intervertebral Disc Repair | Metadata changed |
| May 19, 2026 | CMS / Medicare | Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014. | Metadata changed |
| May 19, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Metadata changed |
| May 19, 2026 | CMS / Medicare | Mohs Micrographic Surgery | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Biomarker Testing for Neuroendocrine Tumors/Neoplasms | Metadata changed |
| May 19, 2026 | CMS / Medicare | Billing and Coding: Molecular Pathology Procedures | Metadata changed |